Clinical Research Directory
Browse clinical research sites, groups, and studies.
CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients
Sponsor: Transplant Genomics, Inc.
Summary
This is a prospective, multi-site, observational study with a matched control group. The primary objective is to evaluate change in renal function over time in recipients of kidney transplants who are undergoing OmniGrafTM monitoring in conjunction with patient medication-related burden monitoring.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2022-09
Completion Date
2026-06-01
Last Updated
2022-08-01
Healthy Volunteers
No
Conditions
Interventions
Patients monitored with OmniGraf testing
This is an observational study there are no protocol mandated interventions. OmniGraf results will be utilized in conjunction with standard of care assessments to determine patient management.